(FOX BUSINESS) – An advisory panel to the CDC unanimously voted to give a preferential recommendation to mRNA vaccines, like those made by Pfizer and Moderna, over the one-shot Johnson & Johnson vaccine due to rare but serious blood clots.
The CDC temporarily halted Johnson & Johnson’s vaccine in April while scientists investigated the blood clots, which are known as "thrombosis with thrombocytopenia syndrome."
Regulators eventually decided that the benefits of the Johnson & Johnson vaccine outweighed the risks, but the FDA released new data this week showing that more cases have occurred in the summer and fall.
The post CDC advisory panel recommends Pfizer, Moderna vaccines over Johnson & Johnson appeared first on WND.
